{
  "symbol": "LLY",
  "year": 2024,
  "period": "Q2",
  "curated_text": "Symbol: LLY. Year: 2024. Period: Q2. ReportType: Q10. Section: Competition and Market Position. This section discusses competitors, market dynamics, and regulatory landscape.  Competitors mentioned: . Context excerpt: competition affecting our products, pipeline, or industry; \u2022 market uptake of launched products and indications; \u2022 continued pricing pressures and the impact of actions of governmental and private payers affecting pricing of, reimbursement for, and patient access to pharmaceuticals, or reporting obligations related thereto; \u2022 safety or efficacy concerns associated with our products; \u2022 dependence on relatively few products or product classes for a significant percentage of our total revenue and an increasingly consolidated supply chain; \u2022 the expiration of intellectual property protection for certain of our products and competition from generic and biosimilar products, and risks from the proliferation of counterfeit or illegally compounded products; \u2022 our ability to protect and enforce patents and other intellectual property and changes in patent law or ",
  "competition_summary": []
}